A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 2006

Conditions
HIV Infections
Interventions
DRUG

Mycophenolate mofetil

DRUG

Amdoxovir

Trial Locations (17)

10003

Beth Israel Med. Ctr., ACTU, New York

10016

NY Univ. HIV/AIDS CRS, New York

15213

Pitt CRS, Pittsburgh

19104

Hosp. of the Univ. of Pennsylvania CRS, Philadelphia

19401

Univ. of Pennsylvania Health System, Presbyterian Med. Ctr., Philadelphia

80262

University of Colorado Hospital CRS, Aurora

95814

UC Davis Medical Center, Sacramento

Univ. of California Davis Med. Ctr., ACTU, Sacramento

96816

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

98104

University of Washington AIDS CRS, Seattle

943055107

Stanford CRS, Palo Alto

90095-1793

UCLA CARE Center CRS, Los Angeles

33136-1013

Univ. of Miami AIDS CRS, Miami

Unknown

Johns Hopkins Adult AIDS CRS, Baltimore

55455-0392

University of Minnesota, ACTU, Minneapolis

63108-2138

Washington U CRS, St Louis

44106-5083

Case CRS, Cleveland

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00038272 - A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV Infection | Biotech Hunter | Biotech Hunter